Medicine
Showing 641-660 of 1,188 Results
-
Anson Lowe
Associate Professor of Medicine (Gastroenterology and Hepatology), Emeritus
Current Research and Scholarly InterestsThe laboratory is focused on the relationship between injury, wound healing, and cancer. Esophageal, gastric, and pancreatic cancers are a focus. We are particularly interested in the regulation of cell signaling by EGFR, the EGF receptor. In addition to cancer pathogenesis, active projects include the development of new diagnostic assays and drugs.
-
Henry J. Lowe, MD
Associate Professor of Medicine (General Medical Disciplines) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsMy research in the field of biomedical informatics over the past 30 years has focused on the development of novel uses of information technology and computer science to improve human health. My current interests include the Electronic Health Record (EHR), biomedical knowledge representation, Internet applications in healthcare, clinical data warehouses, clinical data and text mining, academic social networking and the use of information technology to support clinical and translational research.
-
Robert Lowsky
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsDr. Lowsky's research is focused on understanding the role of regulatory T cells in the prevention of GVHD and in promoting immune tolerance following organ transplantation.
-
Janice Lu
Clinical Professor, Medicine - Oncology
BioDr. Janice Lu is Clinical Professor of Medicine in the Division of Medical Oncology at Stanford University School of Medicine. She specializes in the treatment of breast cancer, with expertise in hormone receptor–positive and HER2-positive disease, antibody-drug conjugates, and immunotherapy. Dr. Lu has led and contributed to multiple clinical trials, including playing a key role in the EMERALD trial, which resulted in FDA approval of the first oral SERD for ESR1-mutated ER+/HER2- metastatic breast cancer. Her translational research focuses on liquid biopsy, epigenetics, AI and multiomics approaches to treatment resistance. She has chaired national sessions on precision oncology and holds leadership roles with NRG Oncology and ASCO, including Vice-Chair of the NRG Immunotherapy Subcommittee and Track Leader for ASCO’s Developmental Therapeutics and Targeted Therapy Education Program. She has also served on committees for the National Comprehensive Cancer Network (NCCN) and the Southwest Oncology Group (SWOG).
Dr. Lu completed her Hematology and Oncology fellowship at New York University School of Medicine and earned a PhD in epigenetics under the mentorship of late Dr. David Allis, a pioneer in the field and 2018 Lasker Laureate. Prior to joining Stanford, she was Director of Breast Medical Oncology and led the Circulating Tumor Cell (CTC) Core Lab at Northwestern University Feinberg School of Medicine, before returning to the Bay Area to be with her family and to further expand research and patient-centered care. -
Sydney X. Lu
Assistant Professor of Medicine (Hematology)
BioSydney Lu is an assistant professor and physician-scientist in the Division of Hematology, Department of Medicine with a broad interest in both normal and abnormal RNA processing in the context of normal physiology and disease states. The laboratory studies translational questions regarding the mechanistic basis of RNA processing abnormalities in malignant blood disorders, their implications for leukemogenesis and cancer biology, as well as resultant therapeutic opportunities.
As a physician, Sydney’s group is particularly focused on dissecting RNA processing abnormalities in primary patient samples and disease-relevant preclinical model systems. Lab members employ a variety of ‘wet-lab’ and computational approaches to study transcriptome abnormalities in (1) states of immune dysfunction, (2) myeloid blood cancers such as myelodysplastic syndromes and acute myeloid leukemia, and (3) lymphoid blood cancers such as chronic lymphocytic leukemia. Additional projects are focused on novel therapeutics, including multiple targeted agents which modulate RNA processing, for the selective treatment of these diseases.
Sydney’s research is/has been supposed by grant funding from the National Cancer Institute, Parker Institute for Cancer Immunotherapy, Leukemia & Lymphoma Society, Aplastic Anemia & Myelodysplastic Syndromes International Foundation, the American Society for Clinical Oncology, the American Society of Hematology, the American Association for Cancer Research, the Paula and Rodger Riney Foundation, the Doris Duke Charitable Foundation, The Gabrielles Angel Foundation for Cancer Research, and the Stanford Cancer Institute. -
Stephen Luby
Lucy Becker Professor of Medicine, Senior Fellow at the Woods Institute for the Environment, Freeman Spogli Institute for International Studies and Professor, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Luby’s research interests include identifying and interrupting environmental pathways of disease in low- and middle-income countries.
-
George Lui
Clinical Professor, Medicine - Cardiovascular Medicine
Clinical Professor, Pediatrics - CardiologyCurrent Research and Scholarly InterestsAdult Congenital Heart Disease
-
Mitchell R. Lunn
Associate Professor of Medicine (Nephrology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsLGBTQIA+ health
-
Kevin M Lutley
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Lutley is a primary care doctor. He is board certified in internal medicine.
For every patient, he creates a customized care plan. Plans focus on helping each person enjoy the best possible health and wellness.
Dr. Lutley has helped advance care through research. He has shared his research discoveries with his peers in invited presentations. Topics include drug prices in community pharmacies and the quality of interactions between patients and resident physicians.
While an internal medicine resident at Stanford, Dr. Lutley served as a member of the Stanford Ambulatory Care Excellence Program. This initiative aims to enhance the quality of outpatient primary care.
Dr. Lutley helps educate the primary care doctors of tomorrow. He is a clinical assistant professor of primary care and population health in the Stanford Department of Medicine, Division of Primary Care.
Before joining Stanford, Dr. Lutley performed needs assessments and care coordination with local public health agencies in Flint, Michigan.
Recognition for his achievements includes induction in the Gold Humanism Honor Society. This national organization honors senior medical students, residents, teachers and others for excellence in clinical care, leadership, and compassion. Additional honors for Dr. Lutley include induction in Alpha Omega Alpha, the honor society in the field of medicine.
From Stanford University, he received the Julian Wolfsohn Award. This honor goes to residents who demonstrate exemplary professionalism, teaching, and dedication to patient care.
Dr. Lutley is a member of the American College of Physicians. -
Raquel Leanne Lyn
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Lyn serves as a Clinical Assistant Professor within the Division of Pulmonary, Allergy, and Critical Care at Stanford University. Specializing in the comprehensive management of pulmonary hypertension, she completed her fellowship in pulmonary and critical care medicine at Stanford in 2021. She furthered her expertise as the 2021-22 Vera Moulton Wall Center eBay Fellow in Pulmonary Vascular Disease.
Today, Dr. Lyn is a member of the Stanford Health Care Adult Pulmonary Hypertension team, serving as a clinician educator and Assistant Director of the Stanford CTEPH program. Her clinical and research interests focus on CTEPH, post-acute PE care and advancing health equity within pulmonary vascular diseases. -
Stephen Ma
Clinical Assistant Professor, Medicine
BioStephen Ma is a Clinical Assistant Professor in the Division of Hospital Medicine at Stanford University School of Medicine. His undergraduate degree was in Electrical Engineering at Princeton University, after which he pursued his MD/PhD at Columbia University. He then moved to Stanford University for his residency in Internal Medicine and fellowship in Clinical Informatics prior to joining the faculty. His clinical expertise is in the care of adult patients admitted to the inpatient general medicine services.
He is fellowship-trained in clinical informatics with the following areas of focus: 1) the implementation and evaluation of emerging technologies such as ambient AI scribes, 2) clinician-centered analytics and reporting, 3) the development of machine learning algorithms and workflows for standardization of care, and 4) care team communication and on-call scheduling. His overall approach to technology integration into healthcare emphasizes user-centered design, data-driven decision making, and rigorous demonstration of outcomes.
He previously performed his doctoral work in the laboratory of Professor Gordana Vunjak-Novakovic where he developed human cardiac models of disease incorporating patient-derived stem cells, optogenetics, tissue engineering, optoelectronics, and video processing. -
Crystal Mackall
Ernest and Amelia Gallo Family Professor and Professor of Pediatrics and of Medicine
Current Research and Scholarly InterestsRecent clinical studies, by us and others, have demonstrated that genetically engineered T cells can eradicate cancers resistant to all other therapies. We are identifying new targets for these therapeutics, exploring pathways of resistance to current cell therapies and creating next generation platforms to overcome therapeutic resistance. We have discovered novel insights into the biology of human T cell exhaustion and developed approaches to prevent and reverse this phenomenon.
-
David Magnus, Ph.D.
Thomas A. Raffin Professor of Medicine and Biomedical Ethics and Professor (Teaching) of Medicine (Primary Care and Population Health)
Current Research and Scholarly InterestsGenetic testing, gene therapy, genetically engineered organisms, and the history of eugenics. Stem cell research and cloning, and egg procurement. Examining ethical issues in reproductive technologies. Organ transplantation including donation after cardiac death, ethics of listing decisions. End of life issues in both adults and children.
-
Kenneth Mahaffey
Professor of Medicine (Cardiovascular Medicine)
BioClinical Focus: Cardiovascular Medicine: Atrial Fibrillation; Chronic CAD; ACS;
Research Focus:
My primary research interest is the design and conduct of multicenter clinical trials and analyses of important clinical cardiac issues using large patient databases. My research focuses on novel anticoagulation agents for the treatment of acute coronary syndromes and atrial fibrillation, the study of agents targeted to protect the myocardium during reperfusion therapy for acute myocardial infarction, and the evaluation of cardiovascular safety of diabetic therapies. I am also interested in the methodology of clinical trials. Current research activities include standardization of the definition of myocardial infarction used in clinical trials, the adjudication of suspected clinical endpoint events by Clinical Event Committees (CEC), and the efficient operational conduct of large multinational clinical trials.
Administrative Focus: Associate Dean, Clinical Research School of Medicine; Vice Chair of Clinical Research Department of Medicine; Director Stanford Center for Clinical Research; Member of the Stanford IRB
Professional Training:
1985 Stanford University, BS Chemistry
1989 University of Washington, MD
1993 University of Arizona, Internship/Residency/Chief Residency
1996 Duke University, Fellowship in Cardiology
1996 Duke University, Faculty in Cardiology
2013 Stanford University, Faculty Cardiovascular Medicine
